Björn Lemmer1, Henrik Oster2. 1. Institute of Experimental and Clinical Pharmacology & Toxicology, Medical Faculty Mannheim, Ruprecht Karls University Heidelberg, Heidelberg, Germany. bjoern.lemmer@medma.uni-heidelberg.de. 2. Chronophysiology, Institute of Neurobiology, University of Lübeck, Lübeck, Germany.
Abstract
PURPOSE OF THE REVIEW: Cellular circadian clocks regulate physiological functions during day and night. It has been convincingly demonstrated that hypertension in patients suffering from diabetes mellitus or metabolic syndrome is characterized in most cases by a disturbed 24-h profile resulting in a nondipper pattern. We consider possible correlation between biological clocks and symptoms of the metabolic syndrome. RECENT FINDINGS: Changes in circadian clock function have been linked to metabolic disorders in genome-wide association studies. Epidemiological studies have shown that a loss of nocturnal decline in blood pressure increases the risk of cardiovascular morbidity and mortality and end-organ damage. Looking at clock genes, however, there is no obvious association between symptoms of diabetes or metabolic syndrome and clock gene expression. Emerging data suggest that circadian rhythm disruption is a risk factor for metabolic and cardiovascular disorders, while disease feedback on clock function is limited.
PURPOSE OF THE REVIEW: Cellular circadian clocks regulate physiological functions during day and night. It has been convincingly demonstrated that hypertension in patients suffering from diabetes mellitus or metabolic syndrome is characterized in most cases by a disturbed 24-h profile resulting in a nondipper pattern. We consider possible correlation between biological clocks and symptoms of the metabolic syndrome. RECENT FINDINGS: Changes in circadian clock function have been linked to metabolic disorders in genome-wide association studies. Epidemiological studies have shown that a loss of nocturnal decline in blood pressure increases the risk of cardiovascular morbidity and mortality and end-organ damage. Looking at clock genes, however, there is no obvious association between symptoms of diabetes or metabolic syndrome and clock gene expression. Emerging data suggest that circadian rhythm disruption is a risk factor for metabolic and cardiovascular disorders, while disease feedback on clock function is limited.
Authors: Pär E son Jennersjö; Magnus Wijkman; Ann-Britt Wiréhn; Toste Länne; Jan Engvall; Fredrik H Nystrom; Carl J Östgren Journal: Prim Care Diabetes Date: 2011-05-05 Impact factor: 2.459
Authors: Steven Hughes; Aarti Jagannath; Mark W Hankins; Russell G Foster; Stuart N Peirson Journal: Methods Enzymol Date: 2014-12-26 Impact factor: 1.600
Authors: Diana E Ayala; Ramón C Hermida; Luisa Chayan; Artemio Mojón; María J Fontao; José R Fernández Journal: Chronobiol Int Date: 2009-08 Impact factor: 2.877
Authors: S Dulong; Q Huang; P F Innominato; A Karaboue; M Bouchahda; A Pruvost; F Théodoro; L A Agrofoglio; R Adam; B Finkenstädt; F Lévi Journal: Sci Rep Date: 2021-12-14 Impact factor: 4.379
Authors: Juan Luis Romero Cabrera; Mercedes Sotos-Prieto; Antonio García Ríos; Steven Moffatt; Costas A Christophi; Pablo Pérez-Martínez; Stefanos N Kales Journal: Front Endocrinol (Lausanne) Date: 2021-11-11 Impact factor: 5.555